Citigroup
MRM

Citigroup’s MEDIROM Healthcare Technologies MRM Stock Holding History

Citigroup’s Portfolio MRM Stock Details MRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-297
Closed -$2K – 6500
2022
Q1 		$2K Buy
+297
New +$2.02K ﹤0.01% 6077

Other funds holding MRM

UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Citigroup's MRM Position: Q2 2022 in Review

Citigroup sold out of MEDIROM Healthcare Technologies (MRM) in Q2 2022, closing a stake of 297 shares — an estimated $2K sold.

Citigroup first reported a position in MRM in Q1 2022 and held it in 1 quarter. The position peaked at $2K in Q1 2022. 1 fund tracked by Wall St. Rank holds MRM as of Q2 2022.

  • Citigroup reported no remaining MEDIROM Healthcare Technologies position as of Q2 2022 after selling out during the quarter.
  • Citigroup sold 297 MEDIROM Healthcare Technologies shares in Q2 2022, an estimated $2K.
  • Citigroup first reported a position in MEDIROM Healthcare Technologies in Q1 2022 and held it in 1 quarter.
  • Citigroup's MEDIROM Healthcare Technologies position peaked at $2K in Q1 2022.
  • 1 fund tracked by Wall St. Rank held MEDIROM Healthcare Technologies as of Q2 2022.

Based on Citigroup's 13F filing for Q2 2022, filed 10 Aug 2022.